References
Ginsberg RJ, Rubinstein LV (1996) Randomized trial of Lobectomy versus limited resection for T1N0 non small cell lung cancer. Ann Thorac Surg 62:1249–1250
Wu Y, Huang ZF, Wang SY, et al. (2002) A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36:1–6
Allen MS, Darling GE, Pechet TT, et al. (2006) Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81: 1013–1019
Pignon JP, Tribodet H, Scagliotti GV, et al. (2008) Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552–3559
PORT Meta-analysis Trialists Group (2005) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev (2):CD002142
Lally BE, Zelterman D, Colasanto JM, et al. (2006) Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 24:2998–3006
Le Chevalier T, Soria JC (2004) Status and trends of chemotherapy for advanced NSCLC. Eur J Cancer Suppl 2:26–33
Mahalingam D, Mita A, Mita MM, et al. (2009) Targeted therapy for advanced non-small cell lung cancers: historical perspective, current practices, and future development. Curr Probl Cancer 33:73–111
Gebski V, Burmeister B, Smithers BM, et al. (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pramesh, C.S. Thoracic cancers — cautious optimism replaces abject nihilism. Indian J Surg 71, 308–309 (2009). https://doi.org/10.1007/s12262-009-0085-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-009-0085-5